The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Patel Gautam since 2019.
This trader's CIK number is 1738054.
At the time of last reporting, Patel Gautam was the Director of Amneal Pharmaceuticals, Inc.. (stock ticker symbol AMRX).
Also see all insider trading activities at Amneal Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AMRX | 0 | $0 | 480,000 | $3,951,025 | 40,258 | $0 |
| 2024 | AMRX | 0 | $0 | 0 | $0 | 76,453 | $0 |
| 2023 | AMRX | 0 | $0 | 0 | $0 | 80,128 | $0 |
| 2022 | AMRX | 0 | $0 | 0 | $0 | 35,406 | $0 |
| 2021 | AMRX | 50,000 | $210,500 | 0 | $0 | 46,218 | $0 |
| 2020 | AMRX | 150,000 | $589,072 | 0 | $0 | 6,459 | $0 |
| 2019 | AMRX | 0 | $0 | 0 | $0 | 6,107 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-16 | AMRX | Sale | 94,906 | 8.02 | 761,146 |
| 2025-06-10 | AMRX | Sale | 56,426 | 8.02 | 452,536 |
| 2025-05-05 | AMRX | Option Ex | 40,258 | .00 | 0 |
| 2025-05-05 | AMRX | Sale | 4,900 | 8.00 | 39,200 |
| 2025-05-02 | AMRX | Sale | 3,768 | 8.00 | 30,144 |
| 2025-04-01 | AMRX | Sale | 80,000 | 8.30 | 664,000 |
| 2025-03-03 | AMRX | Sale | 80,000 | 8.90 | 712,000 |
| 2025-02-03 | AMRX | Sale | 80,000 | 8.14 | 651,200 |
| 2025-01-08 | AMRX | Sale | 62,590 | 8.01 | 501,345 |
| 2025-01-02 | AMRX | Sale | 17,410 | 8.01 | 139,454 |
| 2024-05-10 | AMRX | Option Ex | 76,453 | .00 | 0 |
| 2023-05-10 | AMRX | Option Ex | 80,128 | .00 | 0 |
| 2022-05-08 | AMRX | Option Ex | 35,406 | .00 | 0 |
| 2021-12-17 | AMRX | Buy | 50,000 | 4.21 | 210,500 |
| 2021-05-06 | AMRX | Option Ex | 46,218 | .00 | 0 |
| 2020-05-07 | AMRX | Option Ex | 6,459 | .00 | 0 |
| 2020-03-02 | AMRX | Buy | 32,111 | 3.88 | 124,590 |
| 2020-03-03 | AMRX | Buy | 117,889 | 3.94 | 464,482 |
| 2019-05-08 | AMRX | Option Ex | 6,107 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Gautam (Director of Amneal Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.